Today only 1.6 million of people with diabetes who own a smartphone use a mobile application to manage their diabetes. However, the Research Guidance firm predicts that by 2018 that number will rise to 24 million users, or 7.8% of smartphone owners with diabetes. Changes in the conception of mobile apps, from …

An overview on aspirin use in the prevention of cardiovascular events…. Aspirin is a pharmaceutical drug that has been commercially available since 1899. Although originally used as a pain reliever and fever reducer, significant studies show aspirin can play a role in reducing the risk of cardiovascular disease. Patients with …

How does SGLT-2 inhibitor, ipragliflozon compare to metformin alone?…. Ipragliflozin is an oral medication in development by Astellas Pharma for the treatment of type 2 diabetes. A novel selective sodium glucose co-transporter-2 (SGLT-2) inhibitor, ipragliflozin works similarly to the first in class marketed SGLT-2 inhibitor drug, canagliflozin, by increasing urinary …

Combination well-tolerated in patients with type 2 diabetes…. Ipragliflozin is an oral medication in development by Astellas Pharma for the treatment of type 2 diabetes. A novel selective sodium glucose co-transporter-2 (SGLT-2) inhibitor, ipragliflozin works similarly to the first in class marketed SGLT-2 inhibitor drug canagliflozin by increasing urinary excretion …

Popular nutritional diet method examined by researchers…. 

Can taking a mixture of herbs three times daily help moderate glucose levels?… 

Performing certain activities as little as 30 minutes per week could help reduce risks…. 

Fermentable fibers such as cabbage, beans, and some fruits and vegetables increase satiety….

Could fructosamine and glycated albumin testing soon be as common as A1C?… 

Vegetarian diet may lessen risk of type 2 diabetes….